First Time Loading...
C

China Isotope & Radiation Corp
HKEX:1763

Watchlist Manager
China Isotope & Radiation Corp
HKEX:1763
Watchlist
Price: 10.96 HKD -0.72% Market Closed
Updated: May 4, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

13.2B
+12%
Assets
Growth Rates:
1 Year
+13%
3 Years
+44%
5 Years
+91%
7 Years
-
10 Years
-
8.5B
+16%
Liabilities
Growth Rates:
1 Year
+18%
3 Years
+61%
5 Years
+150%
7 Years
-
10 Years
-
4.7B
+5%
Equity
Growth Rates:
1 Year
+5%
3 Years
+21%
5 Years
+34%
7 Years
-
10 Years
-

Balance Sheet Decomposition
China Isotope & Radiation Corp

13.2B
Assets
8.5B
Liabilities
13.2B
Assets
8.5B
Liabilities
Current Assets 8.2B
Cash & Short-Term Investments 2.9B
Receivables 3.9B
Other Current Assets 1.4B
Non-Current Assets 5B
Long-Term Investments 825.6m
PP&E 3.6B
Intangibles 293.6m
Other Non-Current Assets 276.9m
Current Liabilities 4.3B
Accounts Payable 626.7m
Accrued Liabilities 3.3B
Other Current Liabilities 371.3m
Non-Current Liabilities 4.2B
Long-Term Debt 1.5B
Other Non-Current Liabilities 2.8B

Balance Sheet
China Isotope & Radiation Corp

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
711
1 003
1 479
2 616
2 745
2 556
2 748
2 923
2 892
Cash
711
1 003
1 479
2 616
2 745
2 556
2 748
2 923
2 892
Short-Term Investments
0
0
0
0
0
0
0
0
0
Total Receivables
1 068
1 218
1 507
1 728
2 188
2 369
2 851
3 522
3 896
Accounts Receivables
1 065
1 215
1 507
1 728
2 188
2 369
2 851
3 522
3 896
Other Receivables
3
3
0
0
0
0
0
0
0
Inventory
188
226
263
344
444
590
692
679
814
Other Current Assets
141
127
211
199
263
256
366
389
592
Total Current Assets
2 108
2 575
3 460
4 887
5 640
5 771
6 657
7 544
8 194
PP&E Net
549
608
766
1 340
1 987
2 210
2 513
2 940
3 601
PP&E Gross
549
608
766
1 340
1 987
2 210
2 513
2 940
0
Accumulated Depreciation
451
498
553
606
702
820
961
1 115
0
Intangible Assets
5
13
32
49
108
148
156
161
212
Goodwill
6
6
6
6
44
44
44
31
82
Note Receivable
28
29
31
32
34
35
37
39
49
Long-Term Investments
118
174
183
268
765
776
817
843
826
Other Long-Term Assets
157
179
219
322
265
201
250
232
228
Other Assets
6
6
6
6
44
44
44
31
82
Total Assets
2 970
N/A
3 583
+21%
4 697
+31%
6 904
+47%
8 843
+28%
9 185
+4%
10 474
+14%
11 790
+13%
13 192
+12%
Liabilities
Accounts Payable
110
120
198
170
174
200
338
494
627
Accrued Liabilities
110
129
146
181
172
159
152
3 290
3 256
Short-Term Debt
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
480
0
0
219
120
671
66
217
Other Current Liabilities
1 184
1 224
1 572
1 844
2 365
2 294
2 810
182
154
Total Current Liabilities
1 404
1 953
1 916
2 194
2 929
2 772
3 972
4 031
4 254
Long-Term Debt
60
0
150
150
655
630
185
838
1 478
Deferred Income Tax
0
0
0
8
18
14
17
19
9
Minority Interest
506
546
577
836
1 244
1 614
1 852
2 141
2 446
Other Liabilities
152
157
184
213
238
264
268
292
311
Total Liabilities
2 122
N/A
2 655
+25%
2 828
+6%
3 402
+20%
5 084
+49%
5 294
+4%
6 295
+19%
7 321
+16%
8 498
+16%
Equity
Common Stock
200
200
240
320
320
320
320
320
320
Retained Earnings
637
711
1 615
3 155
3 395
3 539
3 820
4 149
4 373
Unrealized Security Profit/Loss
0
0
0
23
40
29
39
55
0
Other Equity
10
17
14
3
4
3
0
58
0
Total Equity
848
N/A
928
+9%
1 869
+101%
3 502
+87%
3 759
+7%
3 891
+4%
4 179
+7%
4 469
+7%
4 693
+5%
Total Liabilities & Equity
2 970
N/A
3 583
+21%
4 697
+31%
6 904
+47%
8 843
+28%
9 185
+4%
10 474
+14%
11 790
+13%
13 192
+12%
Shares Outstanding
Common Shares Outstanding
240
240
240
320
320
320
320
320
320

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.